Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 24, 2026, Ardent Health, Inc. (the "Company") and Ethan Chernin determined that Mr. Chernin would no longer serve as President, Hospital Services and would depart the Company effective that day. The Company treated Mr. Chernin's departure from the Company as a "Qualifying Termination" pursuant to the Company's Executive Severance Plan (the "Severance Plan"). Mr. Chernin will be entitled to receive severance and related benefits for such a separation, subject to compliance with the terms and conditions of the Severance Plan. The severance and related benefits under the Severance Plan are described further in the proxy statement for the Company's 2025 Annual Meeting of Stockholders, filed on Schedule 14A with the Securities and Exchange Commission on April 8, 2025, and in the Severance Plan, filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the three months ended June 30, 2024 filed with the Securities and Exchange Commission on August 14, 2024.